Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 369 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Polyzos, Stergios A [Clear All Filters]
Helicobacter pylori infection might contribute to esophageal adenocarcinoma progress in subpopulations with gastroesophageal reflux disease and Barrett's esophagus..
Helicobacter. 17(5), 402-3.
(2012). Helicobacter pylori may play a role in both obstructive sleep apnea and metabolic syndrome..
Sleep Med. 13(2), 212-3.
(2012). Helicobacter pylori's potential association with epilepsy..
Seizure. 21(2), 151.
(2012). Hpn protein as a mediator between Helicobacter pylori infection and Alzheimer's disease in sub-populations worldwide..
Med Hypotheses. 78(2), 349-50.
(2012). Ki-67 and Bax expression in esophageal mucosa might have implications in ablative therapies for Barrett's esophagus, dysplasia, and adenocarcinoma..
Surg Endosc. 26(1), 283-4.
(2012). Long term follow-up of patients with prolactinomas and outcome of dopamine agonist withdrawal: a single center experience..
Pituitary. 15(1), 25-9.
(2012). Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumab..
Ther Clin Risk Manag. 8, 295-306.
(2012). Nonalcoholic fatty liver disease: multimodal treatment options for a pathogenetically multiple-hit disease..
J Clin Gastroenterol. 46(4), 272-84.
(2012). Normal bone turnover markers in a patient with active Paget's disease of bone: response to treatment with zoledronic acid..
Endokrynol Pol. 63(4), 312-5.
(2012). Papillary thyroid microcarcinoma presenting as lymph node metastasis--a diagnostic challenge: case report and systematic review of literature..
Hormones (Athens). 11(4), 419-27.
(2012). Potential implications of Helicobacter pylori-related neutrophil-activating protein..
World J Gastroenterol. 18(5), 489-90.
(2012). A rebuttal to the potential anti-tumour benefit of Helicobacter pylori-induced neutrophil-activating protein..
Cancer Immunol Immunother. 61(3), 445-6; discussion 447-51.
(2012). The role of cytokines and adipocytokines in zoledronate-induced acute phase reaction in postmenopausal women with low bone mass..
Clin Endocrinol (Oxf). 77(6), 816-22.
(2012). Serum homocysteine levels in patients with nonalcoholic fatty liver disease..
Ann Hepatol. 11(1), 68-76.
(2012). Is serum IL-17A a useful systemic biomarker in patients with Langerhans cell histiocytosis?.
Mol Ther. 20(1), 6-7.
(2012). Serum osteoprotegerin, RANKL, and Dkk-1 levels in adults with Langerhans cell histiocytosis..
J Clin Endocrinol Metab. 97(4), E618-21.
(2012). Serum vitamin B12 and folate levels in patients with non-alcoholic fatty liver disease..
Int J Food Sci Nutr. 63(6), 659-66.
(2012). Sulfated oxysterols as candidates for the treatment of nonalcoholic fatty liver disease..
Metabolism. 61(6), 755-8.
(2012). Visual vignette. Anaplastic thyroid carcinoma..
Endocr Pract. 18(1), 108.
(2012). Association between Helicobacter pylori infection and fibromyalgia syndrome..
Clin Rheumatol. 30(2), 301-2.
(2011). The association between Helicobacter pylori infection and insulin resistance: a systematic review..
Helicobacter. 16(2), 79-88.
(2011). Coincidental thyroid papillary microcarcinoma in a patient treated for a toxic adenoma of the thyroid..
Arch Iran Med. 14(2), 149-51.
(2011). Denosumab and bisphosphonates: rivals or potential "partners"? A "hybrid" molecule hypothesis..
Med Hypotheses. 77(1), 109-11.
(2011). Effect of spironolactone and vitamin E on serum metabolic parameters and insulin resistance in patients with nonalcoholic fatty liver disease..
J Renin Angiotensin Aldosterone Syst. 12(4), 498-503.
(2011). Helicobacter pylori and insulin resistance association: not just a myth, not yet a fact..
Saudi J Gastroenterol. 17(6), 425-6.
(2011).